Agios Pharma (AGIO) Misses Q4 EPS by 10c

Agios Pharma (NASDAQ: AGIO) reported Q4 EPS of ($1.72), $0.10 worse than the analyst estimate of ($1.62). Revenue for the quarter came in at $7.1 million versus the consensus estimate of $7.94 million.

For earnings history and earnings-related data on Agios Pharma (AGIO) click here.

You May Also Be Interested In

• TJX stock drops as profit outlook falls short of analyst estimates
• Truist's 2Q26 Off-Cycle Earnings Preview for Cybersecurity Software: 'We favor RBRK and SAIL'
• Analog Devices climbs as fiscal Q3 results, Q4 outlook beat forecasts